These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1356055)

  • 41. Thyroid-stimulating immunoglobulins and the control of thyroid function.
    Clague R; Mukhtar ED; Pyle GA; Nutt J; Clark F; Scott M; Evered D; Smith BR; Hall R
    J Clin Endocrinol Metab; 1976 Sep; 43(3):550-6. PubMed ID: 821961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graves' disease in the cervical thyroid and thyroglossal duct remnant: case report and review of literature.
    Buckingham H; Sauerwein TJ; Golding AC
    Endocr Pract; 2006; 12(4):401-5. PubMed ID: 16901795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First reported case of unilateral Graves' disease in the left lobe of a bilobar thyroid gland.
    Chen LC; Green JB
    Thyroid; 2011 Jun; 21(6):683-6. PubMed ID: 21563918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
    Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug.
    Shoda Y; Akiyama H; Yamaguchi T; Inukai T; Kobayashi I; Kondo Y; Kobayashi S
    Exp Clin Endocrinol; 1991 Mar; 97(1):113-6. PubMed ID: 1677893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid gland hemiagenesis with Graves' disease.
    Zangeneh F; Miller JL; Intenzo CM
    Thyroid; 2001 Jun; 11(6):603. PubMed ID: 11442010
    [No Abstract]   [Full Text] [Related]  

  • 54. [Association of thyroid hemiagenesis and Graves disease].
    Hervás Benito I; Vera Espallardo F; Rivas Sánchez A; López Aznar D; Saura Quiles A; Muñoz M; Bello Arques P; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Apr; 20(2):116-9. PubMed ID: 11333821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence of Graves' disease in thyroglossal duct remnants: relapse after total thyroidectomy.
    Basili G; Andreini R; Romano N; Lorenzetti L; Monzani F; Naccarato G; Goletti O
    Thyroid; 2009 Dec; 19(12):1427-30. PubMed ID: 19916864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
    Connors MH; Styne DM
    Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
    Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
    Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioassay of thyroid-stimulating immunoglobulin in cryopreserved human thyroid cells: optimization and clinical evaluation.
    Kraiem Z; Glaser B; Pauker J; Sadeh O; Sheinfeld M
    Clin Chem; 1988 Feb; 34(2):244-9. PubMed ID: 2893670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.